Remove Clinical Development Remove Containment Remove Generic Drugs Remove Generic Pharmaceutical
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

Comirnaty was first approved by the US Food and Drug Administration (FDA) in August 2021 for individuals over the age of 16. It contains the antiviral medications nirmatrelvir and ritonavir. In 2022, Biktarvy generated $10.39 In 2022, Xgeva generated $2.01 Pfizer’s total global revenue from Paxlovid was $18.93

Sales 98